An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Methotrexate Injection
Status: Discontinuation
»Therapeutic Categories: Dermatology; Rheumatology

Nordic Group BV (New 06/13/2023)

Company Contact Information:
909-282-2338

Presentation	Posting Date	Related Information
Reditrex, Injection, 15 mg/.6 mL (NDC 66220-815-22)	06/13/2023	Expiry of last lot marketed: 2023-10-31
RediTrex, Injection, 15 mg/0.6 mL (NDC 66220-815-11)	06/13/2023	Expiry of last lot marketed: 2023-10-31
Reditrex, Injection, 20 mg/.8 mL (NDC 66220-820-22)	06/13/2023	Expiry of last lot marketed: 2023-10-31
RediTrex, Injection, 20 mg/0.8 mL (NDC 66220-820-11)	06/13/2023	Expiry of last lot marketed: 2023-10-31
Reditrex, Injection, 25 mg/1 mL (NDC 66220-825-22)	06/13/2023	Expiry of last lot marketed: 2023-10-31
RediTrex, Injection, 25 mg/mL (NDC 66220-825-11)	06/13/2023	Expiry of last lot marketed: 2023-10-31

Top